1. Lodha Developers:
This Mumbai-based realty company rose 5.4% over two trading sessions after announcing its Q2FY26 results on October 30. Net profit increased 86.5% YoY to Rs 788.7 crore, while revenue grew 44.7% to Rs 3,798.5 crore. Both figures beat forecaster estimates, supported by strong presales and collections.
The company added a new Mumbai Metropolitan Region (MMR) project with a gross development value (GDV) of Rs 2,300 crore in Q2. This brought first-half additions to six projects worth Rs 25,000 crore, meeting its full-year business development guidance in just six months.
Projects delayed by Environmental Clearance (EC) issues are now scheduled for the second half of FY26. A Supreme Court approval in August cleared pending projects, which are primarily in Mumbai. 65% of the year's launches in Mumbai, Pune and Bengaluru are consequently planned for H2.
On the sales outlook, Managing Director Abhishek Lodha said, ”Having delivered more than Rs 4,000 crore of presales consecutively for the last 7 quarters, we are now expected to move up towards the run rate in the high 5,000s or low 6,000s.” Management maintains its full-year presales guidance of Rs 21,000 crore.
The company is expanding beyond its core Mumbai market. Pune and Bengaluru now account for about 30% of total presales. Reflecting on this shift, Lodha said, “When we did our IPO about 4.5 years ago, our total sales from non-Mumbai markets were only 3%.” The company also plans to enter the Delhi NCR market, with a pilot launch planned for FY27.
Following the results, Motilal Oswal maintained its ‘Buy’ rating on Lodha, citing steady presales, a stronger launch pipeline post-environmental clearance, and rising non-Mumbai contributions. The brokerage’s price target of Rs 1,888 implies an upside of 53.9%.
2. State Bank of India (SBI):
This state-owned bank’s stock rose 2.3% over the past week, hitting an all-time high of Rs 971.4 after strong Q2FY26 results. Net profit climbed 6.9% YoY to Rs 21,137.3 crore, beating Forecaster estimates. An exceptional gain of Rs 4,593 crore from selling a 13.2% stake in Yes Bank boosted profits.
Revenue jumped 7.4% to Rs 1.8 lakh crore, supported by the corporate and retail banking segments. The bank’s net interest income (NII) rose 3.3%, surpassing estimates, driven by loan growth across the small & medium enterprises, agriculture, retail, corporate, and overseas advances segments. Asset quality improved, with gross and net non-performing assets declining by 40 bps and 11 bps, respectively.
Following the results, SBI Chairman Challa Sreenivasulu Setty offered guidance for the year. "We expect demand for credit to continue in H2FY26," he noted. "Based on the trend, deposits and credit growth of scheduled commercial banks are expected to range from 11-12% during FY26. However, risks persist from volatile global commodity markets and trade disruptions."
The bank plans to list its subsidiary, SBI Funds Management (SBIFML), through an initial public offering (IPO). SBI will sell a 6.3% stake, while its partner, Amundi India Holding, will divest 3.7%. SBIFML is India’s largest asset management company with assets under management of Rs 12 lakh crore in Q2FY26 and a 15.6% market share. Both companies have initiated the IPO process and expect it to be completed in 2026.
Post results, Nirmal Bang maintains its ‘Buy’ call on SBI, with a higher target price of Rs 1,195 per share, a 25% upside. The brokerage is confident in the bank’s long-term growth, driven by its leadership positions in corporate and retail banking, healthy liquidity on the balance sheet, and strong asset quality. It expects SBI to deliver an NII and net profit CAGR of over 12% each, over FY26-28.
3. Tata Consumer Products:
This tea & coffee player rose 2.8% on November 3, following the announcement of its Q2 results. The company’s net profit grew 11% YoY to Rs 404.5 crore, helped by inventory destocking, lower finance costs, and a Rs 97 crore tax credit. Revenue increased 18% to Rs 4,965.9 crore, led by growth in its India business. The company beat Trendlyne’s Forecaster estimates for revenue by 2.8% and for profit by 10%.
Tata Consumer's India business continued its momentum (up 18%), achieving its second straight quarter of double-digit growth. The Foods division surged, driven by performance in value-added salts and the Tata Sampann staples brand.
The Beverages division benefited from falling tea prices. MD & CEO Sunil D’souza said, “Tea prices declined 20% in Q2. Thanks to a good harvest, we anticipate prices to decline further. Coffee prices remained volatile, specifically due to US tariffs making Brazilian coffee costlier. We expect this volatility to subside and prices to normalise over the coming quarter.” The company projects mid-teens revenue growth for its domestic business in FY26, fueled by higher sales volumes, a push toward premium products, and expansion into high-growth segments.
EBITDA margins declined to 13.5% during the quarter amid cost pressures from its international and non-branded businesses. Management expects an accelerated margin recovery in H2FY26, targeting ~15% by Q4FY26.
Meanwhile, the Starbucks alliance showed a strong recovery in Q2FY26 after a brief slowdown in the quick-service restaurant space. The brand delivered 8% revenue growth, achieved positive same-store sales growth (SSSG), and remained EBITDA positive, signalling healthy core operations. Despite temporary disruptions, the brand continued to expand its menu and footprint, adding 7 new locations, bringing its total to 485 stores across 80 cities.
Motilal Oswal expects Tata Consumer Products to maintain its growth momentum, helped by growth in the core India business on the back of new product launches and volume growth in the tea business. The brokerage has a ‘Buy’ rating on the company with a target price of Rs 1,450.
4. 3M India:
This industrial machinery maker surged over 19% last week after reporting a 43% YoY rise in net profit to Rs 191 crore in Q2FY26. This performance was fueled by lower costs for raw materials and growth across all its business segments. EBITDA margin jumped 370 bps to 20.2%, helped by a better mix of products sold and more efficient supply chain management. It features in a screener of stocks increasing net profit and profit margin (QoQ).
The company’s revenue grew 14%, with all segments contributing to this growth. Safety gear demand, higher auto production, infrastructure spending, and new premium consumer products collectively supported the company’s growth.
To build on this success, the company is increasing its investment in sales and marketing to expand its market presence and support volume growth. MD Ramesh Ramadurai stated that the results reflected disciplined execution and a strong focus on customers, while also acknowledging that the timing of some project orders contributed to the gains.
Analysts expect that the healthcare and consumer segments will maintain their double-digit growth, thanks to upcoming festive season demand and increased spending by institutions. The company's profit margins are expected to remain stable as it continues to focus on selling more high-value, premium products.
Trendlyne classifies the stock as an ‘Expensive Star.’ However, it is considered undervalued based on its current price-to-earnings (PE) ratio and future earnings estimates. The stock has gained over 16% in the last quarter, though its performance over the past year has been flat.
ICICI Securities has maintained its ‘Buy’ rating and raised the target price to Rs 35,700, pointing to its record margins and strength in the safety and industrial segment. The brokerage expects further growth from a recovery in the auto sector and increased infrastructure spending. They project revenue to grow at 11.6% CAGR over FY26-28, while net profit is expected to grow faster at 19.7% CAGR over the same period.
5. Latent View Analytics:
The stock of this data processing services company rose over 3% in the past week after it posted strong Q2FY26 results. The company’s net profit grew 11.3% YoY to Rs 44.4 crore. Revenue saw an even bigger jump, rising 19.3%, thanks to strong demand from its banking, financial services, and consumer goods verticals.
Its Q2 operating revenue surpassed Trendlyne's Forecaster estimate by 1.3%, largely driven by a massive 80% surge in engagement tied to its 'Databricks' data intelligence platform. Management is very optimistic about this area, expecting Databricks-related revenue to grow from $11 million last year to over $19 million this year, with a $50 million target in three years. Its stock features in a screener of companies with no debt.
Fueled by this momentum, management has raised its full-year revenue growth forecast to 19-20%. This optimism is built on the strong growth from Databricks and a growing pipeline of Generative AI projects. However, the company is also investing heavily in these same growth areas like AI and local US hiring, which led it to lower its EBITDA margin guidance for the year to 22-23%.
Addressing concerns about US visas, CEO Rajan Sethuraman stated the company is "not very concerned," as it has already secured the visas it needs for the next year. Management also highlighted a strong future pipeline, noting that several small, early-stage projects are expected to scale into multi-million dollar opportunities, in addition to four other large deals worth over $1 million, currently in progress.
This company's stock has weathered the storm of a volatile global tech sector, dipping over 6% in the last year. However, analysts believe this pullback could be an opportunity, as the stock remains in a P/E ‘Buy’ zone. The average 12-month price target from analysts is Rs 523.7.
Brokerage firm ICICI Direct remains optimistic, keeping its ‘Buy’ rating on the stock while trimming its price target to Rs 500. The firm believes the company is positioned for future growth as clients increasingly adopt its GenAI and Databricks solutions. However, it also notes that the heavy investments in these same areas will likely put some short-term pressure on profit margins.
Trendlyne's analysts identify stocks that are seeing interesting price movements, analyst calls, or new developments. These are not buy recommendations.